Author details

Full Name

G Niklas NorÃ©n

Affiliation

ORCID

Career Start Year

2005

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36469249	Signals of Adverse Drug Reactions Communicated by Pharmacovigilance Stakeholders: A Scoping Review of the Global Literature.	Drug Safety	2023
37804398	Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study.	Drug Saf	2023
35020178	Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports.	Drug Safety	2022
34823833	Consensus clustering for case series identification and adverse event profiles in pharmacovigilance.	Artificial Intelligence in Medicine	2021
32617874	Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting.	Drug Safety	2020
31922665	Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second-generation antipsychotics.	World Psychiatry	2020
32990060	Creating a response space in multiparty classroom settings for students using eye-gaze accessed speech-generating devices.	AAC: Augmentative and Alternative Communication	2020
32617875	Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands.	Drug Safety	2020
30863920	Correction to: vigiGrade: A Tool to Identify Well-Documented Individual Case Reports and Highlight Systematic Data Quality Issues.	Drug Safety	2019
30043385	Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project.	Drug Safety	2018
27638661	Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase.	Drug Safety	2017
28815800	A method for data-driven exploration to pinpoint key features in medical data and facilitate expert review.	Pharmacoepidemiology and Drug Safety	2017
28653790	vigiRank for statistical signal detection in pharmacovigilance: First results from prospective real-world use.	Pharmacoepidemiology and Drug Safety	2017
28560588	The Power of the Case NarrativeÂ - Can it be Brought to Bear on Duplicate Detection?	Drug Safety	2017
27612402	Supporting a child with multiple disabilities to participate in social interaction: The case of asking a question.	Clinical Linguistics and Phonetics	2016
26748507	Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases.	Drug Safety	2016
26951233	Good Signal Detection Practices: Evidence from IMI PROTECT.	Drug Safety	2016
26499102	Cheminformatics-aided pharmacovigilance: application to Stevens-Johnson Syndrome.	Journal of the American Medical Informatics Association : JAMIA	2016
26262116	Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers.	Stud Health Technol Inform	2015
25539877	Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network.	Drug Saf	2015
25687792	Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites.	Drug Safety	2015
25432780	Authors' reply to Harpaz et al. comment on: "Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance".	Drug Safety	2015
25052742	Improved statistical signal detection in pharmacovigilance by combining multiple strength-of-evidence aspects in vigiRank.	Drug Safety	2014
24343765	vigiGrade: a tool to identify well-documented individual case reports and highlight systematic data quality issues.	Drug Safety	2014
24985530	Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest.	Drug Saf	2014
24627310	Performance of probabilistic method to detect duplicate individual case safety reports.	Drug Safety	2014
24661640	Computing limits on medicine risks based on collections of individual case reports.	Theoretical Biology and Medical Modelling	2014
25096955	Pharmacovigilance for a revolving world: prospects of patient-generated data on the internet.	Drug Safety	2014
25005708	Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance.	Drug Safety	2014
21705438	Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery.	Statistical Methods in Medical Research	2013
23869234	The impact of duration of treatment on reported time-to-onset in spontaneous reporting systems for pharmacovigilance.	PLoS ONE	2013
24166228	Empirical performance of the calibrated self-controlled cohort analysis within temporal pattern discovery: lessons for developing a risk identification and analysis system.	Drug Saf	2013
23832706	Outlier removal to uncover patterns in adverse drug reaction surveillance - a simple unmasking strategy.	Pharmacoepidemiology and Drug Safety	2013
23640853	Time-to-onset in spontaneous reports: the possibility to detect the unexpected.	Pharmacoepidemiology and Drug Safety	2013
23640657	The development and evaluation of triage algorithms for early discovery of adverse drug interactions.	Drug Safety	2013
23315297	Key elements in adverse drug interaction safety signals: an assessment of individual case safety reports.	Drug Safety	2013
23521350	Participants' dynamic orientation to folder navigation when using a VOCA with a touch screen in talk-in-interaction.	AAC: Augmentative and Alternative Communication	2013
23695184	Logistic regression in signal detection: another piece added to the puzzle.	Clin Pharmacol Ther	2013
22936214	Quantitative benefit-risk assessment using only qualitative information on utilities.	Medical Decision Making	2012
21638520	Safety surveillance of longitudinal databases: methodological considerations.	Pharmacoepidemiology and Drug Safety	2011
21332249	Reporting patterns indicative of adverse drug interactions: a systematic evaluation in VigiBase.	Drug Safety	2011
20972557	Earlier discovery of pregabalin's dependence potential might have been possible.	European Journal of Clinical Pharmacology	2011
21513364	Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase.	Drug Safety	2011
20553054	A decade of data mining and still counting.	Drug Safety	2010
19886114	Modern methods of pharmacovigilance: detecting adverse effects of drugs.	Clinical Medicine	2009
18840023	Impact of stratification on adverse drug reaction surveillance.	Drug Safety	2008
19026031	Stratification for spontaneous report databases.	Drug Safety	2008
18344185	A statistical methodology for drug-drug interaction surveillance.	Statistics in Medicine	2008
16381072	Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events.	Statistics in Medicine	2006
16013091	A bayesian recurrent neural network for unsupervised pattern recognition in large incomplete data sets.	International Journal of Neural Systems	2005